Tuesday, August 26, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Strong Buy Rating and Raises Price Target for ConnectOne Bancorp

Elaine Mendonca by Elaine Mendonca
January 29, 2024
in Breaking News
0
Banking Trading online
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On January 29, 2024, Daniel Tamayo, an esteemed analyst at Raymond James, expressed his unwavering confidence in ConnectOne Bancorp (NASDAQ:CNOB) by maintaining a Strong Buy rating. In a notable development, Tamayo has revised the price target for CNOB from $26 to $28, signaling his optimism for the company’s future growth.

Tamayo, a seasoned Wall Street analyst, has consistently demonstrated his expertise in the field. While boasting a success rate of 37.5%, he has proven to be a reliable source of investment advice. Although his average return stands at -1.59%, his latest assessment of ConnectOne Bancorp as a Strong Buy showcases his positive outlook on the stock.

As we delve into the intricacies of Tamayo’s analysis, it becomes evident that he sees great potential in ConnectOne Bancorp. His endorsement of the company’s stock suggests a belief in its ability to thrive in the market. With this revised price target, Tamayo anticipates a promising future for ConnectOne Bancorp, underlining the potential for further value appreciation.

Strong Performance of CNOB Stock on January 29, 2024: Trading Near 52-Week High and Above 200-Day Moving Average

On January 29, 2024, CNOB stock demonstrated a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of CNOB shares increased by $0.43 since the market last closed, representing a rise of 1.85%. CNOB opened at $23.46 on January 29, 2024, which was $0.22 higher than its previous close. Trading near the top of its 52-week range is a positive sign for CNOB stock. Additionally, trading above its 200-day simple moving average is another positive indicator for CNOB stock. Overall, the performance of CNOB stock on January 29, 2024, was strong, with the stock trading near the top of its 52-week range and above its 200-day simple moving average.

CNOB Stock Performance on January 29, 2024: Revenue Growth but Declining Net Income Raises Concerns

CNOB Stock Performance on January 29, 2024:

Total revenue for CNOB stood at $504.07 million over the past year, representing a significant increase of 30.25% compared to the previous year. However, when compared to the last quarter, the total revenue remained flat at $133.17 million.

CNOB’s net income witnessed a decline both on a yearly and quarterly basis. The net income for the past year was reported at $87.00 million, reflecting a decrease of 30.36% compared to the previous year. In the last quarter, the net income dropped further to $19.27 million, representing a decline of 9.7% since the previous quarter.

CNOB’s EPS for the past year was reported at $2.07, showing a decline of 31.27% compared to the previous year. In the last quarter, the EPS decreased further to $0.46, representing a decline of 9.95% since the previous quarter.

While CNOB’s total revenue has shown impressive growth over the past year, the decline in net income and EPS raises concerns about the company’s ability to maintain profitability. Investors may be cautious about the recent decline in earnings, which could impact the stock’s performance on January 29, 2024.

Investors and analysts will closely monitor CNOB’s future financial reports to determine whether the recent decline in net income and EPS is a temporary setback or a sign of deeper issues. It will be interesting to see how the stock performs in the coming months and whether the company can regain its profitability and investor confidence.

Tags: CNOB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Fiscal (3)

Stock Market Updates ZIM SOFI and ONMD Experience Surges

MA stock news

Analysis of HighYielding Dividend Stocks in the Financial Sector

Biotechnology Market Capitalization

LiveOne Unveils Groundbreaking Addition Splitmind Radio

Recommended

Jefferies Analyst Upgrades Corbus Pharmaceuticals to Buy Raises Price Target

1 year ago
Block Stock

Block Stock: Downgrade Clashes With S&P 500 Optimism

3 weeks ago
Logistics Stock Market Today (2)

Targets Shipment Disruptions Amidst Red Sea Crisis

2 years ago
FLO stock news

Investor Sentiment and Options Activity for First Solar as of March 6 2024

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE Adobe ADSK ALB AMD AMZN Apple AVGO BA C COIN Coinbase COST CRWD DELL DIS DWAC Eli Lilly EQT GM IBM INTC Intel JPM LLY META Micron MSFT NFLX NIO NVDA NVO Opendoor PARA PLTR Robinhood SMCI Strategy TGT TSLA UNH VZ
No Result
View All Result

Highlights

MSA Safety: A Stock Caught Between Strong Fundamentals and Lofty Valuations

Legend Biotech’s Surging Revenue Fuels Analyst Confidence Despite Ongoing Losses

Prestige Consumer Healthcare Faces Strategic Crossroads After Disappointing Quarter

Major Investor Trims Stake in QuantumScape

Mixed Signals Emerge from Piper Sandler’s Strong Quarterly Performance

Brazilian Steelmaker Cia Siderurgica Nacional Shows Dramatic Loss Reduction

Trending

Lam Research Stock
Stocks

Lam Research Shares Surge as Analysts Revise Targets Upward

by Dieter Jaworski
August 26, 2025
0

Lam Research has once again demonstrated its role as a cornerstone of the semiconductor equipment sector. The...

Repligen Stock

Repligen Stock: Navigating Divergent Signals in Biotech Markets

August 26, 2025
Cleveland-Cliffs Stock

Major Institutions Bet Big on Cleveland-Cliffs Stock

August 26, 2025
MSA Safety Stock

MSA Safety: A Stock Caught Between Strong Fundamentals and Lofty Valuations

August 26, 2025
Legend Biotech Corp Stock

Legend Biotech’s Surging Revenue Fuels Analyst Confidence Despite Ongoing Losses

August 26, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Lam Research Shares Surge as Analysts Revise Targets Upward August 26, 2025
  • Repligen Stock: Navigating Divergent Signals in Biotech Markets August 26, 2025
  • Major Institutions Bet Big on Cleveland-Cliffs Stock August 26, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com